NorthWest Biotherapeutics Inc (NWBO)

[doingmybest]

What do you think is a reasonable prediction of time to see top line data if Nov is the end of the primary data collection is Nov? I am thinking Jan. I am wondering how long they still have to cover expenses with such a low sp. And, since the first and most important domino is the P3 results, all else can start to happen after.

So, does Jan disclosure seem realistic to you and all for such a study? The number of patients is modest but the analysis is deep, though maybe not so for top line.

I am also wondering if they will want to have an agency discussion prior to disclosure under the circumstances, which we still do not yet understand regarding the partial clinical (screening) hold?